Jie Li
Fortuna: 210 M $ al 30/06/2026
Fortuna: 210 M $ al 30/06/2026
En la actualidad, Jie Li ocupa el cargo de presidente de Yichang Humanwell Pharmaceutical Co. Ltd. y presidente de Humanwell Healthcare (Group) Co.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/09/2025 | 86.747.204 ( 5,95 % ) | 210 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Yichang Humanwell Pharmaceutical Co., Ltd.
Yichang Humanwell Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures anesthetic medicines | Presidente | - |
| Empresas | Cargo | Fin |
|---|---|---|
| HUMANWELL HEALTHCARE (GROUP) CO.,LTD. | Director Ejecutivo | - |
Wuhan Zhong Yuan Rui de Biologicals Products Co., Ltd.
Wuhan Zhong Yuan Rui de Biologicals Products Co., Ltd. BiotechnologyHealth Technology Manufactures, research, and develops biological blood products | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Humanwell Healthcare (Group) Co., Ltd.
Humanwell Healthcare (Group) Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes biochemical products and medicines; manufactures electronic computers | Health Technology |
Yichang Humanwell Pharmaceutical Co., Ltd.
Yichang Humanwell Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures anesthetic medicines | Health Technology |
Wuhan Zhong Yuan Rui de Biologicals Products Co., Ltd.
Wuhan Zhong Yuan Rui de Biologicals Products Co., Ltd. BiotechnologyHealth Technology Manufactures, research, and develops biological blood products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.